ObsEva Announces Update on Board of Directors
Ad hoc announcement pursuant to Art.
- Ad hoc announcement pursuant to Art.
- 53 LR of the SIX Swiss Exchange
GENEVA, Switzerland – March 18, 2024 – ObsEva SA (SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that, concurrent to the decision to wind-down the company’s operations, Catarina Edfjäll, Ph.D. has decided to step down from the Board effective today. - “We would like to warmly thank Catarina for her significant contribution to the company over the last years.
- We are grateful to have had the opportunity to work closely with her and we wish her continued success in her future endeavors,” said Ernest Loumaye, Board Chairman.